Antiviral strategies targeting host factors and mechanisms obliging+ ssRNA viral pathogens

S Mahajan, S Choudhary, P Kumar, S Tomar - Bioorganic & Medicinal …, 2021 - Elsevier
The ongoing COVID-19 pandemic, periodic recurrence of viral infections, and the
emergence of challenging variants has created an urgent need of alternative therapeutic …

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

T Shapira, IA Monreal, SP Dion, DW Buchholz… - Nature, 2022 - nature.com
The COVID-19 pandemic caused by the SARS-CoV-2 virus remains a global public health
crisis. Although widespread vaccination campaigns are underway, their efficacy is reduced …

Medicinal chemistry insights into antiviral peptidomimetics

D Ding, S Xu, EF da Silva-Júnior, X Liu, P Zhan - Drug Discovery Today, 2023 - Elsevier
Highlights•Peptidomimetics are an important class of compounds with improved binding
affinities, enhanced metabolic stability, and favorable bioavailability.•Extensive medicinal …

Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions

X Gao, K Zhu, B Qin, V Olieric, M Wang, S Cui - Nature communications, 2021 - nature.com
Although the accessory proteins are considered non-essential for coronavirus replication,
accumulating evidences demonstrate they are critical to virus-host interaction and …

Novel investigational anti-SARS-CoV-2 agent ensitrelvir “S-217622”: a very promising potential universal broad-spectrum antiviral at the therapeutic frontline of …

WA Eltayb, M Abdalla, AM Rabie - ACS omega, 2023 - ACS Publications
Lately, nitrogenous heterocyclic antivirals, such as nucleoside-like compounds, oxadiazoles,
thiadiazoles, triazoles, quinolines, and isoquinolines, topped the therapeutic scene as …

Efficacious preclinical repurposing of the nucleoside analogue didanosine against COVID-19 polymerase and exonuclease

AM Rabie - ACS omega, 2022 - ACS Publications
Analogues and derivatives of natural nucleosides/nucleotides are considered among the
most successful bioactive species of drug-like compounds in modern medicinal chemistry …

Promising experimental anti-SARS-CoV-2 agent “SLL-0197800”: the prospective universal inhibitory properties against the coming versions of the coronavirus

AM Rabie, MA Abdel-Dayem, M Abdalla - ACS omega, 2023 - ACS Publications
Isoquinoline derivatives having some nucleosidic structural features are considered as
candidate choices for effective remediation of the different severe acute respiratory …

Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies

AM Rabie, M Abdalla - ACS bio & med Chem Au, 2022 - ACS Publications
Lately, nucleos (t) ide antivirals topped the scene as top options for the treatment of
coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome …

Attenuation of SARS‐CoV‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases

V Bergant, S Yamada, V Grass, Y Tsukamoto… - The EMBO …, 2022 - embopress.org
The SARS‐CoV‐2 infection cycle is a multistage process that relies on functional
interactions between the host and the pathogen. Here, we repurposed antiviral drugs …

Potent dual polymerase/exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 omicron virus: a promising in silico/in vitro …

AM Rabie, WA Eltayb - Molecular Biotechnology, 2024 - Springer
Recently, natural and synthetic nitrogenous heterocyclic antivirals topped the scene as first
choices for the treatment of the severe acute respiratory syndrome coronavirus 2 (SARS …